Losartan Potassium/Indapamide

氯沙坦钾/吲达帕胺

Report date: 2022/07/29 20:00:35

Base Information

Drug NameLosartan Potassium/Indapamide
Drug Alias Name氯沙坦钾+吲达帕胺Losartan Potassium+Indapamide吲达帕胺+氯沙坦钾Indapamide/Losartan Potassium吲达帕胺/氯沙坦钾 +[6] 
ClassificationSmall molecules
Mechanisms of ActionSymporters inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Symporters
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsYes IndapamideLosartan Potassium
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEms
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEms
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A